Carcinoid tumors are the most frequently encountered endocrine tumors of the gastrointestinal tract. They are most often found in the appendix, although they can arise in any location of the gut. Carcinoid tumors may secrete a variety of bioactive substances, which can cause the complex of symptoms associated with the carcinoid syndrome.
Methods
The authors reviewed the pathology, clinical presentation, and management of carcinoid tumors with an emphasis on the surgical management.
Results
The primary treatment for a carcinoid tumor located anywhere in the gut is surgical. Those who have widely metastatic disease or who are anatomically unresectable may undergo cytoreductive surgical debulking and/or hepatic arterial embolization followed by palliation of symptoms with octreotide, the long-acting somatostatin analog.
Conclusions
The prognosis for patients with carcinoid tumors that are fully resected is excellent. Those with hepatic metastases and the carcinoid syndrome.
Get full access to this article
View all access options for this article.
References
1.
BuchananK.D., JohnstonC.F., O'HareM.M.Neuroendocrine tumors. a European view. Am J Med.1986; 81(suppl 6b): 14–22.
2.
ObergK., ErikssonB.Medical treatment of neuroendocrine gut and pancreatic tumors. Acta Oncol.1989; 28(fasc 3): 425–431.
3.
LanghansT.Ueber einen drusenpolyp im ileum. Virchow Archiv Pathol Anatom Physiol Klin Med.1867; 38: 559–560.
4.
LubarschO.Uber den primaren krebs des ileum nebst bemerkungen uber das gleichzeitige vorkommen von krebs und tuberculose. Virchow Archiv Pathol Anatom Physiol Klin Med.1888; 111: 280–317.
5.
RansomW.B.A case of primary carcinoma of the ileum. Lancet.1890; 2: 1020–1023.
6.
OberndorferS.Karzinoide: tumoren des dunndarms. Frank Z Pathol.1907; 1: 426–429.
7.
GossetA., MassonP.Tumeurs endocrines de l'appendice. Presse Med.1914; 2: 237–240.
8.
RapportM.M., GreenA.A., PageI.H.Partial purification of the vasoconstrictor in beef serum. J Biol Chem.1948; 174: 735–741.
9.
ErspamerV., AseroB.Identification of enteramine, the specific hormone of the enterochromaffin cell system, as 5-hydroxytryptamine. Nature.1952; 169: 800–801.
10.
LembeckF.5-Hydroxytryptamine in a carcinoid tumor. Nature.1953; 172: 910–911.
11.
PernowB., WaldenstromJ.Paroxysmal flushing and other symptoms caused by 5-hydroxytryptamine and histamine in patients with malignant tumors. Lancet.1954; 2: 951–953.
12.
PageJ.H., CorcoranA.C., UdenfriedS.Argentaffinoma as endocrine tumor. Lancet.1955; 1: 198–199.
13.
SogaJ., TazawaK.Pathologic analysis of carcinoids: histologic reevaluation of 62 cases. Cancer.1971; 28: 990–998.
14.
JohnsonL.A., LavinP., MoertelC.G.Carcinoids: the association of histologic growth pattern and survival. Cancer.1983; 51: 882–889.
15.
WilliamsE.D., SandlerM.The classification of carcinoid tumors. Lancet.1963; 1: 238–239.
16.
MoestaK.T., SchlagP.Proposal for a new carcinoid tumour staging system based on tumour tissue infiltration and primary metastasis: a prospective multicenter carcinoid tumour evaluation study. West German Surgical Oncologist's Group. Eur J Surg Oncol.1990; 16: 280–288.
17.
CreutzfeldtW., StockmannF.Carcinoids and carcinoid syndrome. Am J Med.1987; 82: 4–16.
OlneyJ.R., UrdanetaL.F., Al-JurfA.S.Carcinoid tumors of the gastrointestinal tract. Am Surg.1985; 51: 37–41.
20.
RoggoA., WoodW.C., OttingerL.W.Carcinoid tumors of the appendix. Ann Surg.1993; 217: 385–390.
21.
ChejfecG., FalkmerS., AskenstenU.Neuroendocrine tumors of the gastrointestinal tract. Pathol Res Pract.1988; 183: 143–154.
22.
MarshallJ.B., BodnarchukG.Carcinoid tumors of the gut: our experience over three decades and review of the literature. J Clin Gastroenterol.1993; 16: 123–129.
23.
WarrenW.H., GouldV.E.Neuroendocrine neoplasms of the bronchopulmonary tract: a classification of the spectrum of carcinoid to small cell carcinoma and intervening variants. J Thorac Cardiovasc Surg.1986; 91: 674–689.
24.
GilliganC.J., LawtonG.P., TangL.H.Gastric carcinoid tumors: the biology and therapy of an enigmatic and controversial lesion. Am J Gastroenterol.1995; 90: 338–352.
25.
StrodelW.E., VinikA.I., ThompsonN.W.Small bowel carcinoid tumors and the carcinoid syndrome. In: ThompsonN.W., VinikA.I., eds. Endocrine Surgery Update.New York, NY: Grune and Stratton; 1983: 277–291.
26.
MoertelC.L., WeilandL.H., TelanderR.L.Carcinoid tumor of the appendix in the first two decades of life. J Pediatr Surg.1990; 25: 1073–1075.
27.
AkerstromG., MakridisC., JohanssonH.Abdominal surgery in patients with midgut carcinoid tumors. Acta Oncol.1991; 30: 547–553.
28.
BassonM.D., AhlmanH., WangbergB.Biology and management of the midgut carcinoid. Am J Surg.1993; 165: 288–297.
29.
OrloffM.J.Carcinoid tumors of the rectum. Cancer.1971; 28: 175–180.
NorheimI., ObergK., Theodorsson-NorheimE.Malignant carcinoid tumors: an analysis of 103 patients with regard to tumour localization, hormone production, and survival. Ann Surg.1987; 206: 115–125.
32.
ErikssonB., ObergK.Peptide hormones as tumor markers in neuroendocrine gastrointestinal tumors. Acta Oncol.1991; 30: 477–483.
33.
ReaF., BindaR., SpreaficoG.Bronchial carcinoids: a review of 60 patients. Ann Thorac Surg.1989; 47: 412–414.
LoweJ.E., BridgmanA.H., SabistonD.C.Jr. The role of bronchoplastic procedures in the surgical management of benign and malignant pulmonary lesions. J Thorac Cardiovasc Surg.1982; 83: 227–234.
36.
BordiC., YuJ.Y., BaggiM.T.Gastric carcinoids and their precursor lesions: a histologic and immunohistochemical study of 23 cases. Cancer.1991; 67: 663–672.
EckhauserF.E., LloydR.V., ThompsonN.W.Antrectomy for multicentric, argyrophil gastric carcinoids: a preliminary report. Surgery.1988; 104: 1046–1053.
39.
RichardsA.T., HinderR.A., HarrisonA.C.Gastric carcinoid tumours associated with hypergastrinaemia and pernicious anaemia-regression of tumors by antrectomy: a case report. S Afr Med J.1987; 72: 51–53.
40.
DaviesM.G., O'DowdG., McEnteeG.P.Primary gastric carcinoids: a view on management. Br J Surg.1990; 77: 1013–1014.
41.
DeansG.T., SpenceR.A.Neoplastic lesions of the appendix. Br J Surg.1995; 82: 299–306.
42.
ThompsonG.B., van HeerdenJ.A., MartinJ.K.Jr. Carcinoid tumors of the gastrointestinal tract: presentation, management, and prognosis. Surgery.1985; 98: 1054–1063.
43.
GodwinJ.D.Carcinoid tumors: an analysis of 2837 cases. Cancer.1975; 36: 560–569.
44.
RindiG., LuinettiO., CornaggiaM.Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: a clinicopathologic study. Gastroenterology.1993; 104: 994–1006.
45.
VinikA.I., StrodelW.E., LloydR.V.Unusual gastroenteropancreatic tumors and their hormones. In: ThompsonN.W., VinikA.I., eds. Endocrine Surgery Update.New York, NY: Grune and Stratton; 1983: 293–300.
46.
VinikA.I., ThompsonN., EckhauserF.Clinical features of carcinoid syndrome and the use of somatostatin analogue in its management. Acta Oncol.1989; 28(fasc 3): 389–402.
47.
AhlmanH., DahlstromA., GronstadK.The pentagastrin test in the diagnosis of the carcinoid syndrome: blockade of gastrointestinal symptoms by ketanserin. Ann Surg.1985; 201: 81–86.
48.
NorheimI., Theodorsson-NorheimE., BrodeinE.Tachykinins in carcinoid tumors: their use as a tumor marker and possible role in the carcinoid flush. J Clin Endocrinol Metab.1986; 63: 605–612.
49.
NortonJ.A., SugarbakerP.H., DoppmonJ.L.Aggressive resection of metastatic disease in selected patients with malignant gastrinoma. Ann Surg.1986; 203: 352–359.
McEnteeG.P., NagorneyD.M., KvolsL.K.Cytoreductive hepatic surgery for neuroendocrine tumors. Surgery.1990; 108: 1091–1096.
52.
CarrascoC.H., CharnsangavejC., AjaniJ.The carcinoid syndrome: palliation by hepatic artery embolization. AJR Am J Roentgenol.1986; 147: 149–154.
53.
ChoK.J., ReuterS.R., SchmidtR.Effects of experimental hepatic artery embolization on hepatic function. AJR Am J Roentgenol.1976; 127: 563–567.
54.
CoupeM.O., HodgsonH.J.F., HemingwayA.The effect of hepatic artery embolization on survival in the carcinoid syndrome. J Intervent Radiol.1989; 4: 179–181.
55.
MakowkaL., TzakisA.G., MazzaferroV.Transplantation of the liver for metastatic endocrine tumors of the intestine and pancreas. Surg Gynecol Obstet.1989; 168: 107–111.
56.
ArnoldJ.C., O'GradyJ.G., BirdG.L.Liver transplantation for primary and secondary hepatic apudomas. Br J Surg.1989; 76: 248–249.
57.
KvolsL.K.Metastatic carcinoid tumors and the carcinoid syndrome: a selective review of chemotherapy and hormonal therapy. Am J Med.1986; 81: 49–55.
58.
KvolsL.K., MoertelC.G., O'ConnellM.J.Treatment of the malignant carcinoid syndrome: evaluation of a long-acting somatostatin analogue. N Engl J Med.1986; 315: 663–666.
59.
WangbergB., NilssonO., TheodorssonE.The effect of a somatostatin analogue on the release of hormones from human midgut carcinoid tumour cells. Br J Cancer.1991; 64: 23–28.
DiacoD.S., HajarizadehH., MuellerC.R.Treatment of metastatic carcinoid tumors using multimodality therapy of octreotide acetate, intra-arterial chemotherapy, and hepatic arterial chemoembolization. Am J Surg.1995; 169: 523–528.
